ABAXIS, INC.Registration Rights Agreement • May 13th, 2002 • Abaxis Inc • In vitro & in vivo diagnostic substances • California
ABAXIS, INC. ANDRights Agreement • May 16th, 2003 • Abaxis Inc • In vitro & in vivo diagnostic substances • California
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 13th, 2002 • Abaxis Inc • In vitro & in vivo diagnostic substances • California
FORM OF ABAXIS, INC.Offshore Securities Subscription Agreement • November 25th, 1998 • Abaxis Inc • In vitro & in vivo diagnostic substances • California
3240 Whipple Road, Union City, CA 94587 Phone 510 . 675 . 6500 Fax 510 . 441 . 6150 www.abaxis.comEmployment Agreement • August 9th, 2005 • Abaxis Inc • In vitro & in vivo diagnostic substances • California
WITNESSETH:Stock Purchase Agreement • September 29th, 1997 • Abaxis Inc • In vitro & in vivo diagnostic substances • California
RECITALSManagement Rights Agreement • November 25th, 1998 • Abaxis Inc • In vitro & in vivo diagnostic substances
WITNESSETH:Stock Purchase Agreement • September 29th, 1997 • Abaxis Inc • In vitro & in vivo diagnostic substances • California
46 2 Company's common stock, which will be treated as an incentive stock option to the maximum extent permitted under the Internal Revenue Code and the Company's Stock Option Plan, at the stock's fair market value on June 26, 1996, the date of the...Employment Agreement • June 30th, 1997 • Abaxis Inc • In vitro & in vivo diagnostic substances • California
3 4 business or equity securities issuable in connection with stock option or other employee benefit plans), the Company shall send to each Investor who is entitled to registration rights under this Section 2(d) written notice of such determination...Registration Rights Agreement • August 14th, 1997 • Abaxis Inc • In vitro & in vivo diagnostic substances • California
ABAXIS, INC.Securities Subscription Agreement • October 19th, 2000 • Abaxis Inc • In vitro & in vivo diagnostic substances • California
EXHIBIT 10.10 LEASE AGREEMENT BASIC LEASE INFORMATION LEASE DATE: June 21, 2000 LANDLORD: PRINCIPAL DEVELOPMENT INVESTORS, LLC, a Delaware limited liability company LANDLORD'S ADDRESS: c/o Legacy Partners Commercial, Inc. 101 Lincoln Centre Drive,...Lease Agreement • January 10th, 2001 • Abaxis Inc • In vitro & in vivo diagnostic substances • California
2 3 4. Information. The Buyer and its advisors, if any, have been furnished with all materials relating to the business, finances and operations of the Company and materials relating to the offer and sale of the Securities which have been requested by...Securities Purchase Agreement • August 14th, 1997 • Abaxis Inc • In vitro & in vivo diagnostic substances • California
AGREEMENT AND PLAN OF MERGER by and among ZOETIS INC., ZEUS MERGER SUB, INC. and ABAXIS, INC. dated as of May 15, 2018Agreement and Plan of Merger • May 16th, 2018 • Abaxis Inc • Measuring & controlling devices, nec • Delaware
AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of May 15, 2018, by and among Zoetis Inc., a Delaware corporation (“Parent”), Zeus Merger Sub, Inc., a California corporation and an indirect wholly owned subsidiary of Parent (“Merger Sub”), and Abaxis, Inc., a California corporation (the “Company”).
ABAXIS, INC.Securities Subscription Agreement • January 5th, 2001 • Abaxis Inc • In vitro & in vivo diagnostic substances • California
LICENSE AGREEMENTLicense Agreement • August 10th, 2009 • Abaxis Inc • Measuring & controlling devices, nec • Massachusetts
This license agreement provides Abaxis the co-exclusive opportunity to utilize these technologies to expand the Abaxis product portfolio and enter on a large scale the professional veterinary rapid diagnostic market. This includes point of care tests for infectious diseases, hormones and therapeutic drugs. The total market for these types of tests in the animal health and laboratory animal research is estimated to be over $100,000,000 in the United States alone.
1 EXHIBIT 10.22 SECURITY AGREEMENT THIS SECURITY AGREEMENT dated as of March 31, 1997. is made by Abaxis, Inc. (the "Borrower"), a California corporation having its own principal place of business and chief executive office at 1320 Chesapeake Terrace,...Security Agreement • June 30th, 1997 • Abaxis Inc • In vitro & in vivo diagnostic substances • Illinois
Lease Agreement Basic Lease InformationLease Agreement • February 13th, 2001 • Abaxis Inc • In vitro & in vivo diagnostic substances • California
Adjustments to Base Rent: Commencing on January 1, 2002, the monthly Base Rent shall increase to $71,076.72; Commencing on January 1, 2003, the monthly Base Rent shall increase to $73,919.79; Commencing on January 1, 2004, the monthly Base Rent shall increase to $76,876.58; Commencing on January 1, 2005, the monthly Base Rent shall increase to $79,951.64; Commencing on January 1, 2006, the monthly Base Rent shall increase to $83,149.71; Commencing on January 1, 2007, the monthly Base Rent shall increase to $86,475.70; Commencing on January 1, 2008, the monthly Base Rent shall increase to $89,934.73; Commencing on January 1, 2009, the monthly Base Rent shall increase to $93,532.12; and Commencing on January 1, 2010, the monthly Base Rent shall increase to $97,273.40.
SECOND AMENDMENT TO THE EXCLUSIVE AGREEMENT BETWEEN ABBOTT POINT OF CARE INC. AND ABAXIS, INC.Exclusive Agreement • August 9th, 2017 • Abaxis Inc • Measuring & controlling devices, nec • Illinois
This Second Amendment (“Second Amendment”) to that certain Exclusive Agreement (“Agreement”) dated as of March 7, 2017, is effective as of April 19, 2017 (“Amendment Effective Date”) between Abaxis, Inc. (“ABAXIS”) and Abbott Point of Care Inc. (“ABBOTT”) relating to the appointment of ABBOTT to sell and distribute Abaxis Products. Any capitalized term used and not otherwise defined herein shall have the meaning set forth in the Agreement.
Fifth Amendment to Lease AgreementLease Agreement • February 9th, 2016 • Abaxis Inc • Measuring & controlling devices, nec
This Fifth Amendment to Lease Agreement (this “Amendment”) is entered into as of December 17, 2015 (the "Effective Date"), by and among WHIPPLE ROAD HOLDINGS, LLC, a Delaware limited liability company, SFP CROSSROADS, LLC, a Delaware limited liability company, and WOODSTOCK BOWERS, LLC, a Delaware limited liability company (collectively, “Landlord”), and ABAXIS, INC., a California corporation (“Tenant”).
AMENDMENT TO MASTER AGREEMENTMaster Agreement • August 9th, 2013 • Abaxis Inc • Measuring & controlling devices, nec
This Amendment is entered into this 4th of April, 2013, by and among the Kansas State University Institute for Commercialization (“KSUIC”) (f/k/a the National Institute for Strategic Technology Acquisition and Commercialization), a Kansas non-profit corporation, the Kansas State University Research Foundation, a Kansas non-profit corporation (“KSURF”) and ABAXIS, Inc., a California corporation (“ABAXIS”). KSUIC, KSURF, and ABAXIS are collectively referred to as “Parties.”
AGREEMENTAgreement • July 1st, 2002 • Abaxis Inc • In vitro & in vivo diagnostic substances
CONFIDENTIAL DISTRIBUTOR AGREEMENTDistributor Agreement • June 14th, 2012 • Abaxis Inc • Measuring & controlling devices, nec • California
This Agreement made and entered into this 1st day of April, 2010 by and between Lextron, Inc. with its principal office at 620 “O” Street, P.O. Box 1240 Greeley CO 80632 (hereinafter called “Distributor”); and ABAXIS, Inc., a California corporation with its principal office at 3240 Whipple Road, Union City, California 94587 (hereinafter called “ABAXIS”).
EXCLUSIVE AGREEMENTExclusive Agreement • February 11th, 2013 • Abaxis Inc • Measuring & controlling devices, nec
THIS EXCLUSIVE AGREEMENT (“Agreement”) is made and entered into on October 26, 2012 by and between Abbott Point of Care Inc., a Delaware corporation, having its principal place of business at 400 College Road East, Princeton, NJ 08540 (“Abbott”), and Abaxis, Inc., a Delaware corporation with offices at 3240 Whipple Road, Union City, CA 94587 (“Abaxis”), and effective as of January 2, 2013 (“Effective Date”). Abbott and Abaxis are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
CONFIDENTIAL SETTLEMENT AGREEMENTSettlement Agreement • November 9th, 2012 • Abaxis Inc • Measuring & controlling devices, nec • California
This CONFIDENTIAL SETTLEMENT AGREEMENT (the “Agreement”) is entered into effective the 24th day of September 2012 (the “Effective Date”), by and between Abaxis, Inc., a California corporation with its principal place of business at 3240 Whipple Road, Union City, California 94587 (“Abaxis”), and Cepheid, a California corporation with its principal place of business at 904 Caribbean Drive, Sunnyvale, California 94089 (“Cepheid”). Abaxis and Cepheid are hereinafter referred to respectively as a “Party” and collectively as the “Parties.”
MODIFICATION TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • February 12th, 2003 • Abaxis Inc • In vitro & in vivo diagnostic substances
This Third Modification to Loan and Security Agreement (this "Modification") is entered into by and between Abaxis, Inc., a California corporation ("Borrower") and COMERICA BANK-CALIFORNIA, a California banking corporation ("Bank") as of this 21st day of October 2002 at San Jose, California.
ABAXIS, INC. AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT for CLINTON H. SEVERSONExecutive Employment Agreement • February 9th, 2011 • Abaxis Inc • Measuring & controlling devices, nec • California
This Amended and Restated Executive Employment Agreement (“Agreement”) is entered into as of the 27th day of October, 2010 (the “Effective Date”), by and between Clinton H. Severson (“Executive”) and Abaxis, Inc., a California corporation (“Company”). As of the Effective Date, this Agreement amends, restates and supersedes in its entirety the Employment Agreement by and between the Executive and the Company dated July 11, 2005 (“Prior Agreement”).
Second Amendment to Lease AgreementLease Agreement • June 14th, 2010 • Abaxis Inc • Measuring & controlling devices, nec
This Second Amendment to Lease Agreement (the “Amendment”) is made and entered into as of November 20, 2000, by and between PRINCIPAL DEVELOPMENT INVESTORS, LLC, a Delaware limited liability company (“Landlord”), and ABAXIS, INC., a California corporation (“Tenant”), with reference to the following facts.
51 3 WAIVER IS A MATERIAL INDUCEMENT FOR LANDLORD TO ENTER AND ACCEPT THIS AMENDMENT.Lease Agreement • June 30th, 1997 • Abaxis Inc • In vitro & in vivo diagnostic substances
DISTRIBUTION AGREEMENTDistribution Agreement • May 31st, 2016 • Abaxis Inc • Measuring & controlling devices, nec • California
This DISTRIBUTION AGREEMENT (the “Agreement”) is made effective as of October 1, 2014 (the “Effective Date”) by and between Patterson Management, LP, a Minnesota Limited Partnership with an office at 137 Barnum Road, Devens MA 01434 (hereinafter called “Distributor”) and ABAXIS, Inc., a California corporation with its principal office at 3240 Whipple Road, Union City, California 94587 (“ABAXIS”).
LOAN REVISION/EXTENSION AGREEMENTLoan Revision/Extension Agreement • November 13th, 2002 • Abaxis Inc • In vitro & in vivo diagnostic substances
This Loan Revision Agreement refers to the loan evidenced by the above Note dated March 13, 2002 in favor of Bank executed by Abaxis, Inc. in the amount of $1,250,000.00 payable in full on September 11, 2002. Said Note is secured by a Deed of Trust dated N/A (hereinafter referred to as the "Encumbrance"), recorded on N/A as Instrument No. N/A in the Office County Recorder of N/A County California.
ENGAGEMENT AGREEMENTEngagement Agreement • August 14th, 2000 • Abaxis Inc • In vitro & in vivo diagnostic substances • Arizona
MASTER AGREEMENTMaster Agreement • June 13th, 2011 • Abaxis Inc • Measuring & controlling devices, nec • California
This Master Agreement (this “Agreement”) is dated as of January 26, 2011 (“Effective Date”) by and among the National Institute for Strategic Technology Acquisition and Commercialization, a Kansas non-profit corporation (“NISTAC”), the Kansas State University Research Foundation, a Kansas non-profit corporation (“KSURF”) and ABAXIS, Inc., a California corporation (“ABAXIS”). NISTAC, KSURF and ABAXIS are also each referred to as a “Party” or collectively as the “Parties.”
First Amendment to Lease AgreementLease Agreement • June 14th, 2010 • Abaxis Inc • Measuring & controlling devices, nec
This First Amendment to Lease Agreement (the “Amendment”) is made and entered into as of August 28, 2000, by and between Principal Development Investors, LLC, a Delaware limited liability company (“Landlord”) and Abaxis, Inc, a California corporation (“Tenant”), with reference to the following facts.
EMPLOYEE RETENTION INCENTIVE AGREEMENTEmployee Retention Incentive Agreement • August 14th, 2001 • Abaxis Inc • In vitro & in vivo diagnostic substances
THIS EMPLOYEE INCENTIVE AGREEMENT(hereinafter referred to as "Agreement") is made and entered into by and between Alberto Santa Ines (hereinafter referred to as "employee") and Abaxis, Inc. (hereinafter referred to as "Company") on April 13, 2001.
